Search results summary
From Health Canada
Search criteria
- Status: Select all
- AIG: 0119935001
Search results
| Status | DIN | Company | Product | Class | PM See footnote1 | Schedule | # See footnote2 | A.I. name See footnote3 | Strength |
|---|---|---|---|---|---|---|---|---|---|
| Cancelled Post Market | 02243254 | APOTEX INC | APO-MIDAZOLAM INJECTABLE 5 MG/ML | Human | No | TARGETED SUBSTANCES (CDSA IV) | 1 | MIDAZOLAM (MIDAZOLAM HYDROCHLORIDE) | 5 MG / ML |
| Approved | 02559579 | NEURAXPHARM PHARMACEUTICALS, S.L. | BUCCOLAM | Human | Yes | TARGETED SUBSTANCES (CDSA IV) | 1 | MIDAZOLAM (MIDAZOLAM HYDROCHLORIDE) | 2.5 MG / 0.5 ML |
| Approved | 02559587 | NEURAXPHARM PHARMACEUTICALS, S.L. | BUCCOLAM | Human | Yes | TARGETED SUBSTANCES (CDSA IV) | 1 | MIDAZOLAM (MIDAZOLAM HYDROCHLORIDE) | 5 MG / 1 ML |
| Approved | 02559595 | NEURAXPHARM PHARMACEUTICALS, S.L. | BUCCOLAM | Human | Yes | TARGETED SUBSTANCES (CDSA IV) | 1 | MIDAZOLAM (MIDAZOLAM HYDROCHLORIDE) | 7.5 MG / 1.5 ML |
| Approved | 02559609 | NEURAXPHARM PHARMACEUTICALS, S.L. | BUCCOLAM | Human | Yes | TARGETED SUBSTANCES (CDSA IV) | 1 | MIDAZOLAM (MIDAZOLAM HYDROCHLORIDE) | 10 MG / 2 ML |
| Marketed | 02517582 | DECHRA REGULATORY BV | DORMAZOLAM | Veterinary | Yes | TARGETED SUBSTANCES (CDSA IV) | 1 | MIDAZOLAM | 5 MG / ML |
| Marketed | 02240286 | SANDOZ CANADA INCORPORATED | MIDAZOLAM INJECTION | Human | Yes | TARGETED SUBSTANCES (CDSA IV) | 1 | MIDAZOLAM | 5 MG / ML |
| Cancelled Post Market | 02243935 | NOVOPHARM LIMITED | MIDAZOLAM INJECTION | Human | Yes | TARGETED SUBSTANCES (CDSA IV) | 1 | MIDAZOLAM (MIDAZOLAM HYDROCHLORIDE) | 5 MG / ML |
| Cancelled Pre Market | 02383594 | MYLAN PHARMACEUTICALS ULC | MIDAZOLAM INJECTION | Human | Yes | TARGETED SUBSTANCES (CDSA IV) | 1 | MIDAZOLAM (MIDAZOLAM HYDROCHLORIDE) | 5 MG / ML |
| Cancelled Post Market | 02423766 | PFIZER CANADA ULC | MIDAZOLAM INJECTION | Human | Yes | TARGETED SUBSTANCES (CDSA IV) | 1 | MIDAZOLAM | 5 MG / ML |
| Cancelled Pre Market | 02241754 | HOSPIRA HEALTHCARE ULC | MIDAZOLAM INJECTION BP | Human | Yes | TARGETED SUBSTANCES (CDSA IV) | 1 | MIDAZOLAM (MIDAZOLAM HYDROCHLORIDE) | 5 MG / ML |
| Dormant | 02382903 | SANDOZ CANADA INCORPORATED | MIDAZOLAM INJECTION SDZ | Human | Yes | TARGETED SUBSTANCES (CDSA IV) | 1 | MIDAZOLAM | 5 MG / ML |
| Marketed | 02382350 | PFIZER CANADA ULC | MIDAZOLAM INJECTION USP | Human | Yes | TARGETED SUBSTANCES (CDSA IV) | 1 | MIDAZOLAM | 5 MG / ML |
| Marketed | 02382385 | PFIZER CANADA ULC | MIDAZOLAM INJECTION USP | Human | Yes | TARGETED SUBSTANCES (CDSA IV) | 1 | MIDAZOLAM | 5 MG / ML |
| Marketed | 02242905 | FRESENIUS KABI CANADA LTD | MIDAZOLAM INJECTION, USP | Human | Yes | TARGETED SUBSTANCES (CDSA IV) | 1 | MIDAZOLAM | 5 MG / ML |
| Approved | 02529319 | BAXTER CORPORATION | MIDAZOLAM INJECTION, USP | Human | Yes | TARGETED SUBSTANCES (CDSA IV) | 1 | MIDAZOLAM | 5 MG / ML |
| Cancelled Pre Market | 02242654 | PHARMASCIENCE INC | PMS-MIDAZOLAM | Human | No | TARGETED SUBSTANCES (CDSA IV) | 1 | MIDAZOLAM (MIDAZOLAM HYDROCHLORIDE) | 5 MG / ML |
| Cancelled Post Market | 00766011 | HOFFMANN-LA ROCHE LIMITED | VERSED INJ 5MG/ML | Human | No | TARGETED SUBSTANCES (CDSA IV) | 1 | MIDAZOLAM (MIDAZOLAM HYDROCHLORIDE) | 5 MG / ML |
Application information
Related information
Contact us
Version 4.0.3